Digest Network Come funziona
Network
/
Società
Ev
Non verificato

Evaxion

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaPubblicità/Marketing/Media/Comunicazione

26 comunicati stampa

Guarda tutti i comunicati
05/03/2026
Biotecnologia
Annunci Economici
Evaxion announces business update and full year 2025 financial results
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
05/03/2026
Biotecnologia
Annunci Economici
Evaxion plans to file 2025 annual report later today
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
02/03/2026
Biotecnologia
Annunci Economici
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
13/01/2026
Biotecnologia
Annunci Economici
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
07/01/2026
Biotecnologia
Annunci Economici
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
19/12/2025
Biotecnologia
Annunci Economici
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
06/12/2025
Biotecnologia
Annunci Economici
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
20/11/2025
Biotecnologia
Annunci Economici
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
12/11/2025
Biotecnologia
Annunci Economici
Evaxion announce 2026 financial calendar
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
07/11/2025
Biotecnologia
Annunci Economici
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0